Biofrontera

BFRINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$17.377 M

$1.17 +0.86%

Close of 22 Sept 2026

Revenue

$41.7M

#2787 by revenue

Earnings

-$10.5M

Loss-making

Shares outstanding

14,852,359

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Biofrontera lists more than one class of stock. Company figures above cover all classes combined.

BFRIW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#405NewcelXNCEL$17.5M
#406Lantern PharmaLTRN$17.4M
#407BiofronteraBFRI$17.4M
#408Chemomab TherapeuticsCMMB$17.2M
#409Pasithea TherapeuticsKTTA$17.2M

What if Biofrontera were worth as much as…

Open the what-if tool →

Gold $30.2T

$2,035,634

Per share 1,739,858× higher

Bitcoin $1.74T

$117,264.54

Per share 100,226× higher

Nvidia $5.52T

$371,373.13

Per share 317,413× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Biofrontera are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.